Recent Updates
Recently added Catalysts
INO Positive Sentiment Score: 75/100

INOVIO to Present at Upcoming Scientific Conference

Monday, July 7, 2025 1 min read
Key Takeaway: INOVIO (NASDAQ:INO) will present its advancements in DNA medicine at the Orphan Drug Summit in Boston. The company's presentation will focus on the transformative potential of its next generation DNA medicine technology specifically designed for rare diseases. This opportunity to showcase their work at a major conference reflects INOVIO's commitment to combating HPV-related diseases, cancer, and infectious diseases through innovative approaches. The conference is expected to foster collaboration among industry leaders and innovators in the rare disease field.

Market Sentiment Analysis

POSITIVE FACTORS

  • INOVIO is presenting at a significant scientific conference.
  • The focus on next generation DNA medicines highlights innovative approaches.
  • The event gathers industry leaders, indicating strong engagement in rare diseases.

Full Press Release Details

PLYMOUTH MEETING, Pa., July 7, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it will be presenting on the potential of next generation DNA medicine technology in rare disease at the upcoming Orphan Drug Summit in Boston, Massachusetts. The conference brings together industry leaders and innovators in the rare disease space to explore the latest developments in technology and manufacturing.
Time: 4:30-4:55pm ET
Presentation: DMAb Technology: The Transformational Potential of Next Gen DNA Medicine in Rare Disease
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, [email protected]
SOURCE INOVIO Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

What is INOVIO focused on developing?

INOVIO develops DNA medicines for treating HPV-related diseases, cancer, and infections.

Where will INOVIO present its findings?

INOVIO will present at the Orphan Drug Summit in Boston, Massachusetts.

What is the topic of INOVIO's presentation?

The presentation topic is 'DMAb Technology: Next Gen DNA Medicine in Rare Disease.'

When is INOVIO's presentation scheduled?

The presentation is scheduled for July 7, 2025, from 4:30 to 4:55 PM ET.

What does INOVIO's technology achieve?

INOVIO's technology enables the body to produce its own disease-fighting tools.

Tags: INO Viatris Investor Conferences Healthcare INOVIO DNA medicines Orphan Drug Summit rare diseases biotechnology
Last updated: Jul 7, 2025